摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-6-hydroxy-hex-4-enoic acid ethyl ester | 66855-20-7

中文名称
——
中文别名
——
英文名称
(E)-6-hydroxy-hex-4-enoic acid ethyl ester
英文别名
trans-Ethyl-6-Hydroxy-4-hexenoate;ethyl (E)-6-hydroxyhex-4-enoate
(E)-6-hydroxy-hex-4-enoic acid ethyl ester化学式
CAS
66855-20-7
化学式
C8H14O3
mdl
——
分子量
158.197
InChiKey
AGGDACKPJYQQTJ-HWKANZROSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    213.5±28.0 °C(Predicted)
  • 密度:
    1.019±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.5
  • 重原子数:
    11
  • 可旋转键数:
    6
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.62
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] THERAPEUTIC COMPOUNDS<br/>[FR] COMPOSÉS THÉRAPEUTIQUES
    申请人:RESOLVYX PHARMACEUTICALS INC
    公开号:WO2010039531A1
    公开(公告)日:2010-04-08
    The invention relates to novel resolvin compounds and pharmaceutical preparations thereof. The invention further relates to methods of treatment using the novel resolvin compounds of the invention.
    这项发明涉及新型resolvin化合物及其制药制剂。该发明还涉及使用该发明的新型resolvin化合物进行治疗的方法。
  • Ubiquinone and related compounds. XXXI. Synthesis of urinary metabolites of ubiquinone, phylloquinone, .ALPHA.-tocopherol and their related compounds.
    作者:MASAZUMI WATANABE、KAYOKO OKAMOTO、ISUKE IMADA、HIROSHI MORIMOTO
    DOI:10.1248/cpb.26.774
    日期:——
    Metabolites (XVIIa, b, c) of ubiquinone, phylloquinone and α-tocopherol, and their 2', 3'-dihydro (XXa, b, c), dicarboxy (XVIa, b, XXIIIa, b, c, XXIVa, b and XXVa, b) and 3'-demethyl (XXIa, b) derivatives were synthesized. During the synthetic studies of these compounds, we found that cis-4-acetoxy-1-bromo-2-methyl-2-butene (cis-III) was more reactive to nucleophiles than the corresponding trans isomer. γ-Vinyl-γ-butyrolactone (XII), which was a useful starting material for the synthesis of XXIa, b, was synthesized in one step from 1, 3-butadiene. The 3'-methyl group of XVIIa, b was not essential for the membrane-stabilizing activity in the rat-liver lysosome. Introduction of a carboxyl but not a carboxyl ester group into XVIIa, b resulted in a loss of the stabilizing activity.
    合成了泛醌、叶醌和α-生育酚的代谢物(XVIIa, b, c)及其2', 3'-二氢(XXa, b, c)、二羧基(XVIa, b, XXIIIa, b, c, XXIVa, b 和 XXVa, b)和3'-去甲基(XXIa, b)衍生物。在这些化合物的合成研究过程中,我们发现顺-4-乙氧基-1-溴-2-甲基-2-丁烯(cis-III)对核苷酸反应性比相应的反异构体更强。γ-乙烯基-γ-丁内酯(XII)作为合成XXIa, b的有用起始材料,可以一步从1, 3-丁二烯合成。XVIIa, b的3'-甲基基团对大鼠肝脏溶酶体的膜稳定活性并不是必需的。将羧基引入XVIIa, b,而不是羧酸酯基团,会导致稳定活性的丧失。
  • Asymmetric Synthesis of α-Substituted Aldehydes by Pd-Catalyzed Asymmetric Allylic Alkylation−Alkene Isomerization−Claisen Rearrangement
    作者:Barry M. Trost、Ting Zhang
    DOI:10.1021/ol0624878
    日期:2006.12.1
    Enantiospecific aliphatic Claisen rearrangement was realized with generally high chirality transfer. The requisite substrates were synthesized via Pd-catalyzed asymmetric allylic alkylation (AAA) from easily obtained starting materials. After protection, the resultant bisallyl ethers underwent olefin isomerization and in situ Claisen rearrangement (ICR) to generate alpha-chiral aldehydes. Remarkable chemoselectivity
    [结构:见正文]通过通常的高手性转移实现了对映体特异性的脂族克莱森重排。必需的底物是通过Pd催化的不对称烯丙基烷基化反应(AAA)从容易获得的起始原料合成的。保护后,将所得的双烯丙基醚进行烯烃异构化和原位克莱森重排(ICR),以产生α-手性醛。在烯烃异构化步骤中观察到显着的化学选择性。应用该方法完成了Commununiol A的不对称合成。
  • Novel process for preparing 4-amino-5-hexenoic acid
    申请人:MERRELL PHARMACEUTICALS INC.
    公开号:EP0546906A2
    公开(公告)日:1993-06-16
    This invention relates to a novel synthesis of 4-amino-5-hexenoic acid by thermal rearrangements, and to the novel intermediates produced thereby.
    本发明涉及一种通过热重排合成 4-氨基-5-己烯酸的新方法,以及由此产生的新型中间体。
  • Ethyl 6-formyl-4-hexenoate
    申请人:MERRELL PHARMACEUTICALS INC.
    公开号:EP0718273A1
    公开(公告)日:1996-06-26
    This invention relates to the ethyl 6-formyloxy-4-hexenoate which is useful for the preparation of 4-amino-5-hexenoix acid.
    本发明涉及可用于制备 4-氨基-5-己烯酸的 6-甲酰氧基-4-己烯酸乙酯。
查看更多